The government will eliminate the spectator limit of 10,000 for large venues in November but will apply a restriction of 50 ...
Novavax (NASDAQ:NVAX) has received regulatory approval in Japan for its COVID-19 vaccine, Nuvaxovid, which has resulted in a milestone payment from Takeda (NYSE:TAK) (OTCPK:TKPHF), the company said on ...
While Covid-19 infections have decreased significantly since Japan downgraded the disease to the same category as seasonal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results